Optic Neuritis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight
(Albany, US) DelveInsight has launched a new report on
"Optic Neuritis
- Market Insights, Epidemiology, and Market Forecast-2030".
DelveInsight's "Optic
Neuritis - Market Insights, Epidemiology, and Market Forecast-2030" report
delivers an in-depth understanding of the Optic Neuritis, historical and
forecasted epidemiology as well as the Optic Neuritis market trends in the
United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and
Japan.
·
A rare condition with an estimated annual
incidence of 6.4 per 100,000 cases in population in the United States.
·
ON is most common among adults, age 20 to 40
years, and its symptoms generally improve in 80 percent of patients over few
weeks.
·
More females are affected than males and
approximately five out of every one-hundred thousand people are affected by ON
every year
View Report: https://www.delveinsight.com/report-store/optic-neuritis-market
Request for free
sample report: https://www.delveinsight.com/sample-request/optic-neuritis-market
- The
report covers the descriptive overview of Optic Neuritis, explaining its
causes, signs and symptoms, pathophysiology, diagnosis and currently
available therapies
- Comprehensive
insight has been provided into the Optic Neuritis epidemiology and
treatment in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Optic Neuritis are provided, along with the assessment of new therapies,
which will have an impact on the current treatment landscape
- A
detailed review of Optic Neuritis market; historical and forecasted is
included in the report, covering drug outreach in the 7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Optic Neuritis market
Optic
Neuritis (ON) is the
swelling of the eye’s optic nerve. The optic nerve carries light signals from
the back of the eye to the brain so that a person can see. A person cannot see
clearly if the optic nerve is swollen, damaged or is infected.
It is an acute rare disorder which usually occurs in one
eye, and is being characterized by the symptoms including blurring of vision, a
loss of part or all of central vision, reduced color vision, and dimness of
vision.
Most patients with ON have eye pain which characteristically
worsen with movement of the eye.
View Report: https://www.delveinsight.com/report-store/optic-neuritis-market
Request for free
sample report: https://www.delveinsight.com/sample-request/optic-neuritis-market
Some of
the companies covered:
·
Biogen
·
Mitochon Pharmaceuticals
·
Noveome Biotherapeutics
·
And Many Others
·
Opicinumab
·
MP101
·
ST266
·
And Many Others
View Report: https://www.delveinsight.com/report-store/optic-neuritis-market
Request for free
sample report: https://www.delveinsight.com/sample-request/optic-neuritis-market
1. Key Insights
2. Executive Summary
of Optic Neuritis
3. Competitive
Intelligence Analysis for Optic Neuritis
4. Optic Neuritis:
Market Overview at a Glance
4.1. Optic Neuritis Total Market Share (%) Distribution in
2017
4.2. Optic Neuritis Total Market Share (%) Distribution in
2030
5. Optic Neuritis:
Disease Background and Overview
5.1. Introduction
5.2. Sign and Symptoms
5.3. Pathophysiology
5.4. Risk Factors
5.5. Diagnosis
6. Patient Journey
7. Optic Neuritis
Epidemiology and Patient Population
7.1. Epidemiology Key Findings
7.2. Assumptions and Rationale: 7MM
7.3. Epidemiology Scenario: 7MM
7.3.1. Optic Neuritis Epidemiology Scenario in the 7MM
(2017-2030)
7.4. United States Epidemiology
7.4.1. Optic Neuritis Epidemiology Scenario in the United
States (2017-2030)
7.5. EU-5 Country-wise Epidemiology
7.5.1. Germany Epidemiology
7.5.1.1. Optic Neuritis Epidemiology Scenario in Germany
(2017-2030)
7.5.2. France Epidemiology
7.5.2.1. Optic Neuritis Epidemiology Scenario in France
(2017-2030)
7.5.3. Italy Epidemiology
7.5.3.1. Optic Neuritis Epidemiology Scenario in Italy
(2017-2030)
7.5.4. Spain Epidemiology
7.5.4.1. Optic Neuritis Epidemiology Scenario in Spain
(2017-2030)
7.5.5. United Kingdom Epidemiology
7.5.5.1. Optic Neuritis Epidemiology Scenario in the United
Kingdom (2017-2030)
7.5.6. Japan Epidemiology
7.5.6.1. Optic Neuritis Epidemiology Scenario in Japan
(2017-2030)
8. Treatment
Algorithm, Current Treatment, and Medical Practices
8.1. Optic Neuritis Treatment and Management
8.2. Optic Neuritis Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of
Optic Neuritis Treatment
11. Marketed
Products
11.1. List of Marketed Products in the 7MM
11.2. Drug Name: Company Name
11.2.1. Product Description
11.2.2. Regulatory Milestones
11.2.3. Other Developmental Activities
11.2.4. Pivotal Clinical Trials
11.2.5. Summary of Pivotal Clinical Trial
List to be continued in report
12. Emerging
Therapies
12.1. Key Cross
12.2. Drug Name: Company Name
12.2.1. Product Description
12.2.2. Other Developmental Activities
12.2.3. Clinical Development
12.2.4. Safety and Efficacy
12.2.5. Product Profile
List to be continued in report
13. Optic Neuritis:
Seven Major Market Analysis
13.1. Key Findings
13.2. Optic Neuritis Market Size in 7MM
13.3. Optic Neuritis Market Size by Therapies in the 7MM
14. Attribute
analysis
15. 7MM: Market
Outlook
15.1. United States: Market Size
15.1.1. Optic Neuritis Total Market Size in the United
States
15.1.2. Optic Neuritis Market Size by Therapies in the
United States
15.2. EU-5 countries: Market Size and Outlook
15.3. Germany Market Size
15.3.1. Optic Neuritis Total Market Size in Germany
15.3.2. Optic Neuritis Market Size by Therapies in Germany
15.4. France Market Size
15.4.1. Optic Neuritis Total Market Size in France
15.4.2. Optic Neuritis Market Size by Therapies in France
15.5. Italy Market Size
15.5.1. Optic Neuritis Total Market Size in Italy
15.5.2. Optic Neuritis Market Size by Therapies in Italy
15.6. Spain Market Size
15.6.1. Optic Neuritis Total Market Size in Spain
15.6.2. Optic Neuritis Market Size by Therapies in Spain
15.7. United Kingdom Market Size
15.7.1. Optic Neuritis Total Market Size in the United
Kingdom
15.7.2. Optic Neuritis Market Size by Therapies in the
United Kingdom
15.8. Japan Market Outlook
15.8.1. Japan Market Size
15.8.2. Optic Neuritis Total Market Size in Japan
15.8.3. Optic Neuritis Market Size by Therapies in Japan
16. Access and
Reimbursement Overview of Optic Neuritis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight
Capabilities
22. Disclaimer
23. About DelveInsight
View Report: https://www.delveinsight.com/report-store/optic-neuritis-market
Request for free
sample report: https://www.delveinsight.com/sample-request/optic-neuritis-market
About DelveInsight
DelveInsight is a premier Business Consulting and Market
Research firm focused exclusively on the life science segment. With a wide
array of smart end-to-end solutions, the firm helps the global Pharmaceutical
and Bio-Tech companies formulate prudent business decisions for
Browse through our vast repository from here.
Media Contact
Company Name: DelveInsight
Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment